DK0835325T3 - In vitro testmetode til påvisning afkemikalieinducerede embryotoksiske/teratogene virkninger - Google Patents

In vitro testmetode til påvisning afkemikalieinducerede embryotoksiske/teratogene virkninger

Info

Publication number
DK0835325T3
DK0835325T3 DK96922735T DK96922735T DK0835325T3 DK 0835325 T3 DK0835325 T3 DK 0835325T3 DK 96922735 T DK96922735 T DK 96922735T DK 96922735 T DK96922735 T DK 96922735T DK 0835325 T3 DK0835325 T3 DK 0835325T3
Authority
DK
Denmark
Prior art keywords
pct
cells
detection
differentiation
tissue
Prior art date
Application number
DK96922735T
Other languages
English (en)
Inventor
Anna Magdalene Wobus
Wolfgang-Michael Franz
Original Assignee
Inst Pflanzengenetik & Kultur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7766572&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0835325(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Inst Pflanzengenetik & Kultur filed Critical Inst Pflanzengenetik & Kultur
Application granted granted Critical
Publication of DK0835325T3 publication Critical patent/DK0835325T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK96922735T 1995-06-28 1996-06-27 In vitro testmetode til påvisning afkemikalieinducerede embryotoksiske/teratogene virkninger DK0835325T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19525285A DE19525285C2 (de) 1995-06-28 1995-06-28 In vitro Testverfahren zum Nachweis Chemikalien-induzierter embryotoxischer/teratogener Effekte
PCT/DE1996/001183 WO1997001644A1 (de) 1995-06-28 1996-06-27 In vitro-testverfahren zum nachweis chemikalien-induzierter embryotoxischer/teratogener effekte

Publications (1)

Publication Number Publication Date
DK0835325T3 true DK0835325T3 (da) 2001-07-16

Family

ID=7766572

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96922735T DK0835325T3 (da) 1995-06-28 1996-06-27 In vitro testmetode til påvisning afkemikalieinducerede embryotoksiske/teratogene virkninger

Country Status (7)

Country Link
US (1) US6007993A (da)
EP (1) EP0835325B1 (da)
AT (1) ATE199400T1 (da)
DE (2) DE19525285C2 (da)
DK (1) DK0835325T3 (da)
ES (1) ES2156283T3 (da)
WO (1) WO1997001644A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01005745A (es) * 1998-12-09 2003-07-14 Vistagen Inc Tipificacion de la toxicidad utilizando cuerpos embrioides.
AU2001268449A1 (en) 2000-06-14 2001-12-24 Vistagen, Inc. Toxicity typing using liver stem cells
AU2002241758A1 (en) * 2000-10-26 2002-06-18 University Of Florida Drug screening system
IL160507A0 (en) * 2001-08-24 2004-07-25 Advanced Cell Tech Inc Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
EP1641912B1 (en) 2003-06-20 2016-04-27 Axiogenesis Ag Tissue modelling in embryonic stem (es) cell system
ITMI20040467A1 (it) * 2004-03-12 2004-06-12 Istituto Sperimentale Italiano Uso di gameti ed embrioni preimpianto per la determinazione della tossicita' di composti biologicamente attivi
JP4814875B2 (ja) 2004-05-11 2011-11-16 アキシオジェネシス エージー ｉｎｖｉｔｒｏ分化細胞に基づく薬物発見のための検定
US8431397B2 (en) * 2004-09-14 2013-04-30 The Trustees Of Columbia University In The City Of New York Differentiation of human mesenchymal stem cells to cardiac progenitor cells that promote cardiac repair
WO2006032054A2 (en) * 2004-09-14 2006-03-23 The Trustees Of Columbia University In The City Of New York Differentiation of human mesenchymal stem cells to cardiac progenitor cells that promote cardiac repair
CA2613529A1 (en) * 2005-06-22 2007-01-04 Geron Corporation Reporter hepatocytes and other cells for drug screening and toxicity testing
US20060292694A1 (en) * 2005-06-22 2006-12-28 Roslin Institute Reporter hepatocytes and other cells for drug screening and toxicity testing
US20060292695A1 (en) * 2005-06-22 2006-12-28 Roslin Institute Methods and kits for drug screening and toxicity testing using promoter-reporter cells derived from embryonic stem cells
US9155762B2 (en) * 2005-12-08 2015-10-13 University Of Louisville Research Foundation, Inc. Uses and isolation of stem cells from bone marrow
PL2535403T3 (pl) * 2005-12-08 2019-10-31 Univ Louisville Res Found Inc Bardzo małe komórki macierzyste typu embrionalnego (VSEL) oraz sposoby ich izolowania i zastosowania
WO2007084585A2 (en) * 2006-01-19 2007-07-26 Magee-Womans Health Corporation Non-human primate embryonic stem and germ cells: methods of use and methods of making same
GB0911060D0 (en) 2009-06-26 2009-08-12 Ge Healthcare Uk Ltd Methods for predicting the toxicity of a chemical
WO2011115993A2 (en) * 2010-03-15 2011-09-22 The Johns Hopkins University Method for determining substance non-toxicity
JP5814337B2 (ja) * 2010-03-22 2015-11-17 ステミナ バイオマーカー ディスカバリー， インコーポレイテッド ヒト幹細胞様細胞及びメタボロミクスを使用した医薬のヒト発生毒性の予測
RU2685914C1 (ru) 2013-12-11 2019-04-23 Регенерон Фармасьютикалс, Инк. Способы и композиции для направленной модификации генома
WO2021015611A1 (en) * 2019-07-19 2021-01-28 Toxys B.V. Methods to determine the effect of an agent on mammalian embryonic development.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744909A (en) * 1987-02-02 1988-05-17 Vertech Treatment Systems, Inc. Method of effecting accelerated oxidation reaction
EP0390857A4 (en) * 1987-12-15 1991-04-17 The Trustees Of Princeton University Transgenic testing systems for mutagens and carcinogens
EP0370813A3 (en) * 1988-11-25 1991-06-19 Exemplar Corporation Rapid screening mutagenesis and teratogenesis assay
US5346812A (en) * 1989-09-07 1994-09-13 The University Of Miami Teratogen assay

Also Published As

Publication number Publication date
DE59606520D1 (de) 2001-04-05
EP0835325B1 (de) 2001-02-28
DE19525285A1 (de) 1997-01-02
WO1997001644A1 (de) 1997-01-16
DE19525285C2 (de) 1999-04-15
ES2156283T3 (es) 2001-06-16
ATE199400T1 (de) 2001-03-15
US6007993A (en) 1999-12-28
EP0835325A1 (de) 1998-04-15

Similar Documents

Publication Publication Date Title
DK0835325T3 (da) In vitro testmetode til påvisning afkemikalieinducerede embryotoksiske/teratogene virkninger
Lin et al. Bone metastatic LNCaP‐derivative C4‐2B prostate cancer cell line mineralizes in vitro
Xirodimas et al. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo
Paradiso et al. ROS production and scavenging under anoxia and re-oxygenation in Arabidopsis cells: a balance between redox signaling and impairment
DK0898701T3 (da) Fremgangsmåde til at bestemme modenheden og kvaliteten af frø og apparat til at sortere frø
AU680575B2 (en) Retinoid receptor compositions, antibodies and methods
ES2121078T3 (es) Clonacion y expresion de anticuerpos monoclonales humanizados contra interleuquina-4 humana.
DE69417037T2 (de) Identifizierung von liganden durch selektive vermehrung von, durch rezeptoren tranzfizierten zellen
CA2403817A1 (en) Methods of modulating hair growth
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
Schwartzkopff et al. Cysteine-specific ubiquitination protects the peroxisomal import receptor Pex5p against proteasomal degradation
Duke et al. Blue light-induced gene expression alterations in cultured neurons are the result of phototoxic interactions with neuronal culture media
TR199800657T1 (xx) J�venil hormon ya da onun agonistlerinden birinin kimyasal ligand olarak resept�r arac�l� transaktivasyon taraf�ndan ger�ekle�tirilen bitkilerdeki gen ekspresyonunu kontrol etmesi.
Kahounová et al. Slug-expressing mouse prostate epithelial cells have increased stem cell potential
Ni et al. Applications of the MTT assay to functional studies of mouse intestinal intraepithelial lymphocytes
Hoyk et al. Aromatase and estrogen receptor beta expression in the rat olfactory bulb: Neuroestrogen action in the first relay station of the olfactory pathway?
ATE415487T1 (de) Biologisches testverfahren für thyroid stimulierende antikörper
NO954781L (no) Fremgangsmåter for screening av substanser med en modulerende virkning på en interleukin-5-reseptoravhengig cellulær signaloverföringsvei
Rousseau et al. Glucocorticoid hormones increase the activity of plasma membrane alkaline phosphodiesterase I in rat hepatoma cells.
Damjanovski et al. Role of ECM remodeling in thyroid hormone‐dependent apoptosis during anuran metamorphosis
NZ517216A (en) Screening for UDP-glucose: glycoprotein glucosyltransferase (UGGT) activity
Goel et al. UCHL-1 protein expression specifically marks spermatogonia in wild bovid testis
Zito et al. Regulative specification of ectoderm in skeleton disrupted sea urchin embryos treated with monoclonal antibody to Pl‐nectin
ATE297999T1 (de) Dna expression in transfizierten zellen und testverfahren in transfiziereen zellen
Silva et al. In vitro models for studying induction of cytochrome P450 enzymes